BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20491765)

  • 1. BRG1 expression is increased in human cutaneous melanoma.
    Lin H; Wong RP; Martinka M; Li G
    Br J Dermatol; 2010 Sep; 163(3):502-10. PubMed ID: 20491765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
    Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
    Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.
    Hill DA; Chiosea S; Jamaluddin S; Roy K; Fischer AH; Boyd DD; Nickerson JA; Imbalzano AN
    J Cell Sci; 2004 Nov; 117(Pt 24):5847-54. PubMed ID: 15537831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.
    Kidder BL; Palmer S; Knott JG
    Stem Cells; 2009 Feb; 27(2):317-28. PubMed ID: 19056910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
    Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
    Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.
    Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N
    Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
    Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
    Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
    Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
    Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
    Tu N; Hu Y; Mivechi NF
    J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
    Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
    Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes.
    Vradii D; Wagner S; Doan DN; Nickerson JA; Montecino M; Lian JB; Stein JL; van Wijnen AJ; Imbalzano AN; Stein GS
    J Cell Physiol; 2006 Jan; 206(1):112-8. PubMed ID: 15965950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When the SWI/SNF complex remodels...the cell cycle.
    Muchardt C; Yaniv M
    Oncogene; 2001 May; 20(24):3067-75. PubMed ID: 11420722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a.
    Becker TM; Haferkamp S; Dijkstra MK; Scurr LL; Frausto M; Diefenbach E; Scolyer RA; Reisman DN; Mann GJ; Kefford RF; Rizos H
    Mol Cancer; 2009 Jan; 8():4. PubMed ID: 19149898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.